Linetsky David
SEC CIK 1776729 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PHR | Phreesia, Inc. | SVP, Network Solutions | 419.7K | — | $9.40M | 120 | 2020-02-21 | 2026-09-18 |
Most active insiders at PHR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Pale Fire Capital SICAV a.s. | 10% | $18.30M | — |
| 2 | Pale Fire Capital SE | 10% | $10.46M | — |
| 3 | Hoffman Allison C | GC, Sec | — | $537.1K |
| 4 | Indig Chaim | CEO, Dir | — | $421.0K |
| 5 | Linetsky David | Pres, Network Solutions | — | $347.2K |
| 6 | Gandhi Balaji | CFO | — | $291.8K |
| 7 | Roberts Evan | Pres, Provider Solutions | — | $281.9K |
| 8 | Hui Yvonne | Principal Accounting Off | — | $168.5K |
| 9 | VanDuyn Amy Beth | SVP, Human Resources | — | $105.8K |
| 10 | Egbuonu-Davis Lisa | Dir | — | $30.0K |
Transactions 120
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-14 | 2022-09-12 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | F - Tax | $29.19 | -626 | 225.4K | -0.3% | -$18.3K | |
| 2022-09-14 | 2022-09-12 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | A - Grant | — | +1,589 | 226.1K | +0.7% | — | |
| 2022-07-15 | 2022-07-14 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | F - Tax | $22.35 | -1,315 | 224.5K | -0.6% | -$29.4K | |
| 2022-04-18 | 2022-04-13 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | A - Grant | — | +9,253 | 229.4K | +4% | — | |
| M | 2022-04-18 | 2022-04-13+ | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | F - Tax | $28.32 | -3,569 | 225.8K | -2% | -$101.1K |
| 2022-01-19 | 2022-01-14 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | A - Grant | $0.00 | +53.4K | 224.8K | +31% | $0 | |
| M | 2022-01-19 | 2022-01-15+ | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | F - Tax | $35.55 | -4,667 | 220.5K | -2% | -$165.9K |
| DM | 2022-01-07 | 2022-01-06 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | M - OptEx | $5.32 | +30.9K | 164.7K | +23% | +$164.7K |
| DM | 2021-11-09 | 2021-11-05+ | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | S - Sale+OE | $75.14 | -4,977 | 140.4K | -3% | -$374.0K |
| DM | 2021-11-09 | 2021-11-05+ | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | M - OptEx | $4.71 | +4,977 | 141.9K | +4% | +$23.4K |
| D | 2021-11-02 | 2021-11-01 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | M - OptEx | $4.71 | +5,451 | 145.8K | +4% | +$25.7K |
| DM | 2021-11-02 | 2021-11-01 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | S - Sale+OE | $70.88 | -5,451 | 140.4K | -4% | -$386.4K |
| D | 2021-10-15 | 2021-10-15 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | M - OptEx | $4.71 | +5,452 | 145.8K | +4% | +$25.7K |
| D | 2021-10-15 | 2021-10-15 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | S - Sale+OE | $65.36 | -5,452 | 140.4K | -4% | -$356.3K |
| DM | 2021-09-02 | 2021-08-31+ | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | M - OptEx | $4.71 | +5,452 | 145.4K | +4% | +$25.7K |
| DM | 2021-09-02 | 2021-08-31+ | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | S - Sale+OE | $70.54 | -5,452 | 140.4K | -4% | -$384.6K |
| DM | 2021-08-31 | 2021-08-27 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | S - Sale+OE | $71.85 | -21.5K | 140.4K | -13% | -$1.54M |
| D | 2021-08-31 | 2021-08-27 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | M - OptEx | $2.55 | +21.5K | 161.8K | +15% | +$54.7K |
| DM | 2021-08-27 | 2021-08-25+ | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | S - Sale+OE | $70.06 | -1,300 | 140.4K | -0.9% | -$91.1K |
| DM | 2021-08-27 | 2021-08-25+ | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | M - OptEx | $2.55 | +1,300 | 141.2K | +0.9% | +$3,315 |
Purchase Sale Sale after option exercise All abbreviations